Categories AlphaGraphs, Earnings, Technology

CRM Earnings: Key quarterly highlights from Salesforce’s Q1 2023 financial results

Salesforce (NYSE: CRM) reported first quarter 2023 earnings results today.

Total revenue increased 24% year-over-year to $7.41 billion. Revenue growth was 26% in constant currency.

GAAP net income was $28 million, or $0.03 per share, compared to $469 million, or $0.50 per share, in the same period last year. Adjusted EPS was $0.98.

Both the top and bottom line numbers beat expectations, sending the stock up 7% in after-market hours.  

For the second quarter of 2023, Salesforce expects GAAP loss per share of $0.03-0.02. For the full year of 2023, the company expects GAAP EPS of $0.38-0.40.

Prior performance

Salesforce reports Q4 2022 earnings results

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Infographic: Highlights of DocuSign’s (DOCU) Q1 2024 results

DocuSign, Inc. (NASDAQ: DOCU), a leading provider of electronic signature solutions, Thursday reported first-quarter earnings. It also provided guidance for the second quarter and fiscal 2024. The company's top line

Macy’s (M): A few points to consider if you have an eye on this retailer

Shares of Macy’s, Inc. (NYSE: M) stayed in red on Thursday. The stock has dropped 22% year-to-date and 32% over the past 12 months. The retailer witnessed sales and profit

Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said its scientific co-founder Dr. Jonathan Kurtis received a new patent

Add Comment
Viewing Highlight